Investors in Gilead Sciences can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Analysts expect a dividend of 2,27 USD per share. Thus the dividend yield equals 3,14 percent. The average dividend yield of the biotech companies is a limited 0,5 percent.
Tomorrow the American Gilead Sciences will publish its past quarter's figures. Over the current book year the total revenue will be 21,42 billion USD (consensus estimates). This is quite lower than 2017's revenue of 26,11 billion USD.
The analysts expect for 2018 a net profit of 8,73 billion USD. According to most of the analysts the company will have a profit per share for this book year of 6,62 USD. The price/earnings-ratio therefore equals 10,93.
Based on the current number of outstanding shares Gilead Sciences 's market capitalization is 94,55 billion USD. The Gilead Sciences stock was the past 12 months quite unstable. Since last October the stock is 7 percent lower. This year the stock price moved between 64 and 90 dollar. Since 2008 the stock price is almost 218 percent higher.On Monday, the stock closed at 72,34 USD.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.